Am Heart J

1. PETERSEN JK, Schops LB, Melchior S, Baker K, et al
   Admission with heart failure or atrial fibrillation before mitral valve surgery and associated outcomes.
   Am Heart J. 2026 Mar 2:107397. doi: 10.1016/j.ahj.2026.107397.
   

   >> Share

   
   

   
   Am J Cardiol

2. DE SOUZA MDW, Deluca AP, de Oliveira JP, Dandamudi M, et al
   Revisiting Beta-blockers in Heart Failure with Preserved Ejection Fraction- A Systematic Review and Meta-Analysis.
   Am J Cardiol. 2026 Mar 2:S0002-9149(26)00107.
   

   >> Share

   
   

   
   Circulation

3. ZHANG Z, Zhu D, Liu C, Gan L, et al
   Small Extracellular Vesicle External Surface Adiponectin-Mediated Adipocytes/Cardiomyocytes Communication in Diabetic Ischemic Heart Failure.
   Circulation. 2026 Mar 2. doi: 10.1161/CIRCULATIONAHA.125.076372.
   

   >> Share

   
   

   
   Eur Heart J

4. JIN K, Tang Y, Zhan J, Zhou Y, et al
   Nuclear AGO2 exacerbates heart failure with preserved ejection fraction through myocardial ketogenesis.
   Eur Heart J. 2026 Mar 5:ehag067. doi: 10.1093.
   

   >> Share

   
   
5. SANTOVITO D, Weber C
   Argonaute nuclear power: nuclear microRNAs control cardiac metabolism in heart failure with preserved ejection fraction.
   Eur Heart J. 2026 Mar 5:ehaf841. doi: 10.1093.
   

   >> Share

   
   
6. GALLO G, Volpe M
   Weekly Journal Scan: Estimated efficacy of a combined three-pillar drug treatment in the management of heart failure with mildly reduced or preserved ejection fraction.
   Eur Heart J. 2026 Mar 5:ehag135. doi: 10.1093.
   

   >> Share

   
   
7. EGOROVA AD
   Addressing the blind spot: identifying heart failure with preserved ejection fraction in adults with congenital heart disease.
   Eur Heart J. 2026 Mar 5:ehag130. doi: 10.1093.
   

   >> Share

   
   
8. MOURA B, Sousa A, Bayes-Genis A
   Europe's heart failure landscape: the persistent under-recognition of HFpEF.
   Eur Heart J. 2026 Mar 5:ehaf981. doi: 10.1093.
   

   >> Share

   
   
9. ABA N, Le Teuff G, Fresneau B, Koscielny S, et al
   Transcriptomic biomarkers related to cardiac disease in childhood cancer survivors: a case-control study.
   Eur Heart J. 2026;47:1066-1080.
   

   >> Share

   
   

   
   Eur J Heart Fail

10. SOLTANI F, Black N, Bradley J, Priestner L, et al
    Characterising the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from risk.
    Eur J Heart Fail. 2026 Mar 5:xuag056. doi: 10.1093.
    

    >> Share

    
    

    
    J Card Fail

11. BERGMANN O, Tseliou E, Sadek H, Drakos SG, et al
    LVAD-mediated Unloading and Circulatory Support as a Potential Regenerative Strategy in Advanced Heart Failure.
    J Card Fail. 2026 Mar 2:S1071-9164(26)00081.
    

    >> Share

    
    

    
    J Cardiol

12. MIYAHARA D, Kida K, Nabeta T, Yoshioka K, et al
    Prognostic value of the clinical phenotype in patients with cardiac sarcoidosis: SARCO phenotype.
    J Cardiol. 2026;87:230-237.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share